Eton Pharmaceuticals
Stock Forecast, Prediction & Price Target
Eton Pharmaceuticals (ETON) stock Price Target by analysts
$13
Potential downside: -19.75%
Eton Pharmaceuticals price prediction
What is Eton Pharmaceuticals stock analysts` prediction?
Eton Pharmaceuticals stock forecast: Based on 2 Wall Street analysts` predicted price targets for Eton Pharmaceuticals in the last 3 months, the avarage price target is $13, with a high forecast of $NaN. The average price target represents a -19.75% change from the last price of $16.2.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Eton Pharmaceuticals stock Price Target by analysts
Full breakdown of analysts given Eton Pharmaceuticals price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Chase Knickerbocker Craig-Hallum | 0% 0/2 | 10 months ago | $15 -7.40% downside | $8.44 | StreetInsider | Previous targets (1) |
Swayampakula Ramakanth H.C. Wainwright | 0% 0/1 | 11 months ago | $11 -32.09% downside | $6.91 | TheFly | Previous targets (0) |
Chase Knickerbocker Craig-Hallum | 0% 0/2 | over 1 year ago | $8 -50.61% downside | $3.71 | TheFly | Previous targets (1) |
Unknown H.C. Wainwright | N/A | almost 3 years ago | $10 -38.27% downside | $2.07 | Benzinga | N/A |
Unknown H.C. Wainwright | N/A | about 3 years ago | $9 -44.44% downside | $2.72 | Benzinga | N/A |
Eton Pharmaceuticals Financial Estimates
Eton Pharmaceuticals Revenue Estimates
Eton Pharmaceuticals EBITDA Estimates
Eton Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $21.83M N/A | $21.25M -2.66% | $31.64M 48.89% | Avg: $47.4M Low: $46.41M High: $48.38M avg. 49.80% | |||
Net Income
% change YoY
| $-2.96M N/A | $-9.78M -230.36% | $-936K 90.43% | Avg: $7.1M Low: $6.73M High: $7.11M avg. 858.54% | |||
EBITDA
% change YoY
| $-1.03M N/A | $-6.48M -527.87% | $-291K 95.51% | Avg: $-22.38M Low: $-22.85M High: $-21.92M avg. -7593.85% | |||
EPS
% change YoY
| -$0.12 N/A | -$0.39 -225.00% | -$0.04 90.64% | Avg: $0.27 Low: $0.26 High: $0.28 avg. 839.72% | |||
Operating Expenses
% change YoY
| $20.70M N/A | $22.57M 9.05% | $22.25M -1.43% | Avg: $3.19B Low: $3.13B High: $3.26B avg. 14264.62% | |||
FAQ
What is Eton Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 858.54% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is 6.73M, average is 7.1M and high is 7.11M.
What is Eton Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 49.80% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $46.41M, average is $47.4M and high is $48.38M.
What is Eton Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 839.72% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is $0.26, average is $0.27 and high is $0.27.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Eton Pharmaceuticals stock. The most successful analyst is Chase Knickerbocker.